NDC 71225-114
Icatibant
Icatibant
Icatibant is a Subcutaneous Injection in the Human Prescription Drug category. It is labeled and distributed by Slayback Pharma Llc. The primary component is Icatibant Acetate.
Product ID | 71225-114_5ccd1185-cbec-4c7f-a654-95f8ff1a7e01 |
NDC | 71225-114 |
Product Type | Human Prescription Drug |
Proprietary Name | Icatibant |
Generic Name | Icatibant |
Dosage Form | Injection |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 2020-09-03 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA211501 |
Labeler Name | Slayback Pharma LLC |
Substance Name | ICATIBANT ACETATE |
Active Ingredient Strength | 30 mg/3mL |
Pharm Classes | Bradykinin B2 Receptor Antagonist [EPC],Bradykinin B2 Receptor Antagonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |